12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gregory Sullivan
Tonix Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Denver
Denver, Colorado, United States
- 16176 Cortez Boulevard
Brooksville, Florida, United States
- 100 West Gore Street
Orlando, Florida, United States
- 71 Thomas Johnson Drive
Frederick, Maryland, United States
- 370 Faunce Corner Road
North Dartmouth, Massachusetts, United States
- Worcester
Worcester, Massachusetts, United States
- Jackson
Jackson, Mississippi, United States
- Cincinnati
Cincinnati, Ohio, United States
- 1275 Olentangy River Road
Columbus, Ohio, United States
- 18660 Bagley Road
Middleburg Heights, Ohio, United States
- 1001 South Market Street
Mechanicsburg, Pennsylvania, United States
- 322 Memorial Drive
Greer, South Carolina, United States
- 601 Broadway
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2013
- Primary completion
- 31 Aug 2015
- Completion
- 31 Aug 2015
- Last update posted
- 7 Jul 2017
- Registered enrollment
- 158
- Registry id
- NCT02015234
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.